Bruce Horowitz, Chief Operations Consultant
Mr. Horowitz is a member of the Board and has served as the Managing Director of Capital Strategists, LLC, which provides corporate, strategic, and financial consulting services, since September 2006. He also serves as a trusted advisor to family trusts and private individuals, with a focus on financial asset management, real estate management and special situation investments. Earlier in his career Mr. Horowitz was a charter member of the New York Futures Exchange, a Senior Vice President managing principal equity investment accounts, private equity investments and public offerings at Drake Capital Securities, and managed the trading department at Laidlaw Equities. He was also a partner at Stanley Capital, a private equity buyout firm. Mr. Horowitz was the chairman and a member of two general obligation bond fund committees, raising more than $500 million in general revenue bonds for the Beverly Hills Unified School District. Subsequently, he was named the first chairman of both the state of California-mandated Citizens’ Oversight Committee and Facilities Advisory Committee, overseeing expenditure of all BHUSD general obligation bond funds. Mr. Horowitz is a founding member of the Los Angeles Chapter of the Positive Coaching Alliance. He founded and is currently the president of the Beverly Hills Basketball League, a youth basketball program that serves more than 35,000 families. Mr. Horowitz has also served as a member of the board of directors of the American Youth Soccer Organization and Beverly Hills Little League. He holds a Juris Doctor degree from Benjamin N. Cardozo School of Law in New York City and Bachelor of Arts degree from Washington University in St. Louis.
Tim Scott, President
Tim Scott, Ph.D., has served in senior management positions at Photogen Technologies, Inc.; Genase LLC; and the Oak Ridge National Laboratory. Holder of 28 U.S. patents, Scott was a co-founder, senior scientist, vice president and chief operating officer for Photogen Technologies. Scott also served as Photogen's interim CEO and chairman during the company's restructuring. While working at Genase, Scott's duties included design and licensing of recombinant DNA-derived and other enzyme-based products. Before that, as director of bioprocessing at the Oak Ridge National Laboratory, Scott achieved a national presence in the use of advanced biotechnology for the production of energy, fuels and chemicals. Several of his innovative products have been licensed to the oil and gas and biotechnology industries. Awards include an R&D 100 for an industrial enzyme, the National Laboratory Consortium Award for Excellence in Technology Transfer, the Inventor's Forum Advanced Technology Award, and the Martin Marietta Energy Systems Inventor of the Year Award. Scott also has served as adjunct associate professor of chemical engineering at the University of Tennessee, Knoxville. Scott holds a Ph.D. in chemical engineering from University of Wisconsin, Madison. He earned his bachelor's degree in chemical engineering from the University of Tennessee.
Eric Wachter, Chief Technology Officer
Eric Wachter, Ph.D., has served in senior management positions at Photogen Technologies and the Oak Ridge National Laboratory. A holder of 30 U.S. patents, he was a co-founder of Photogen Technologies and served the company as a director, secretary, vice president and senior scientist. Responsibilities included pre-clinical development and clinical testing both of photodynamic therapy pharmaceuticals and photoactivation systems. At Oak Ridge, Wachter conducted research and development of advanced nanosensor and remote sensor technologies in the environmental and biomedical sciences, as well as for defense and transportation applications. While with Photogen, he was responsible for photonic product development and testing, and for managing Photogen's intellectual property portfolio. Awards include an R&D 100 for nanosensors, an R&D 100 for laser metrology, the Inventor's Forum Advanced Technology Award, the Excellence in Research Award from the Oak Ridge National Laboratory, and an Upjohn Fellowship. Wachter holds a Ph.D. in chemistry from the University of Wisconsin, Madison and a bachelor's degree in chemistry from Indiana University-Bloomington.
John Glass, Interim CFO
Mr. Glass was named Interim Chief Financial Officer of Provectus Biopharmaceuticals, Inc. in April 2016. He is the President of J.R. Glass & Associates, a consulting firm he founded in 1990. From January 2007 to May 2014, Mr. Glass served as controller for CytoCore, Inc., now known as Medite Cancer Diagnostics Inc., a late development stage bio molecular diagnostics company. His prior chief financial officer experience includes serving as Chief Financial Officer of U. S. RealTel, Inc., a publicly traded company in the telecommunications industry, Vice President and Chief Financial Officer of Health Charge Corporation, a financial services company in the health care industry, and Vice President and Chief Financial Officer of Aluminum Distributors, Inc., a metal processor and distributor. Mr. Glass is chairman of the Plan Commission of Elk Grove Village, a member of the Illinois CPA Society and past chairman and member of the board of directors for the Greater O’Hare Service Corporation. He received his B.B.A. in Accounting from Loyola University.